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Isolating Antibiotic-Producing Bacteria From Soil
Michelle Santiago and Dr. Lori Scott
METHODS

INTRODUCTION
The misuse of antibiotics, such as persistent use or simply not
finishing the prescribed dosage, and nosocomial (medically
acquired bacteria) pathogens can be detrimental to the health of
an individual as it causes bacteria, specifically the ESKAPE
pathogens, to become resistant to such antibiotics. The ESKAPE
pathogens (Enterococcus faecium, Staphylococcus aureus,
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, and Enterobacter species) are those that make up
most of the antibiotic-resistant infections in medical settings (1).
As a way to help fight off those bacteria, emerging strategies have
been developed, such as antibiotic combinations, bacteriophage
therapy, antimicrobial peptide therapy, and photodynamic light
therapy (2). Unfortunately, these ESKAPE pathogens are
becoming more resistant and there are simply not enough
antibiotic combinations to successfully eliminate the strains (2).
Microbes are proliferating and revolutionizing much faster than
antibiotics being discovered, further contributing to this crisis.
Due to this complication, the Tiny Earth Project was created. The
project focuses on educating students about the antibiotic
adversity and to find novel antibiotics from soil (1). For this
projects, ESKAPE-like strains will be utilized to minimize
exposure to pathogens, and the TEPI protocol was followed
unless otherwise noted. Contribution to the TEPI project will
allow us to discover potential antibiotic-producing bacteria from
soil.
Our soil isolates will be tested on two ESKAPE-like strains:
Escherichia coli and Bacillus subtilis. E. coli is a safe relative of
Klebsiella pneumoniae and is gram-negative, rod-shaped (bacilli),
and use flagella for motility. E. coli grown on solid medium will
display round, dull colonies that are white in color with entire
margins (3). Most E. coli can be harmless and a part of the normal
flora in an individual, but some strains can cause harm, such as
diarrhea or urinary tract infections (UTI) (3).
Bacillus subtilis is not considered pathogenic (unless exposed to
immunocompromised individuals) and is commonly used as a
fungicide/pesticide in farms because of its spore-forming nature
(4). B. subtilis, as given away by its name, is also bacilli in shape.
This strain is Gram-positive, therefore, there is a thick layer of
peptidoglycan in its cell wall. B. subtilis has an interesting colony
morphology as it grows rapidly, and the edges are rough and
irregular (5). Our contribution to the TEPI project is vital in order
to find potential antibiotic producers from soil. As more
antibiotics are discovered, nosocomial infections will hopefully
decline and mechanisms to oppose the ESKAPE pathogens will
be discovered.

Unless described otherwise, the bacterial strains and protocols used
in this study were provided by the Tiny Earth Project Initiative
(TEPI) (1).
• Obtained rich soil sample from a garden (depth= 4 in.) at 41.4
°N, 90.5° E.
• Dilution of soil sample using PBS
• Created spread plates on different media (LB, 10% TSA, PDA).
Analyzed after 24-72 hours of incubation at 28 ℃
• Master plate created and incubated for 24 hours at 28 ℃
• Tested for antibiotic production using Bacillus subtilis or
Escherichia coli. Incubated at 28 ℃
• Analyzed for possible “halos” around the isolates placed on
either B. subtilis or E. coli and created streak plates. Isolates
were re-streaked again to confirm antibiotic production
• PCR and Gel Electrophoresis (1% agarose) for 30 minutes at
100 V.
• Gel extraction and sequenced at Iowa Institute of Human
Genetics, University of Iowa. The primers used were 27F and
1492R.
• Biochemical tests, including Gram stain, and were performed
following supplier instructions
• Used NCBI BLAST for genus analysis.

RESULTS
When creating the spread plates of B. subtilis and E. coli to test
against the soil isolates, it was observed that E. coli grew on LB
agar but did not grow as well on the more selective mediums (10%
TSA, PDA). This may be an explanation as to why the isolates did
not produce an antibiotic against E. coli. Since E. coli did not grow
well, the isolates might not have been inclined to produce an
antibiotic in order to compete for resources. Therefore, the only
inhibition zones were observed against B. subtilis. Of those isolates,
three were chosen to re-test for antibiotic production. Only two
confirmed antibiotic production against B. subtilis (MS-9-LB-B.
subtilis, MS-36-TSA- B. subtilis). Strangely enough, MS-36-TSA
had originally produced a zone of inhibition on 10% TSA and LB
agar but when screened again, it only produced it on LB agar. MS-9LB-B. subtilis remained consistent as it produced the “halo” on LB
agar and 10% TSA.
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Fig.1. Successful master plates created from soil isolates were
incubated for 24 hours at 28 ℃ (A= LB agar, B= 10% TSA, C= PDA).
These isolates were tested on Escherichia coli and Bacillus subtilis to
determine if antibiotic-producing activity was present.

Fig. 2. Second screening of the soil
isolates to confirm antibiotic
production on either B. subtilis
and/or E. coli on LB agar and 10%
TSA media (A= B. subtilis on 10%
TSA, B= B. subtilis on LB, C= E.
coli on 10% TSA, D= E. coli on LB)
The plates were divided into three
sections: isolate #9 (top), isolate #21
(middle), isolate #36 (bottom). #9
displayed a strong “halo” in A and B.
#21 did not display a “halo” in any of
the conditions. #36 displayed a subtle
“halo” in plate B.

The three isolates that were re-screened (MS-9-LB-B. subtilis, MS36-TSA- B. subtilis, MS-21-TSA-B. subtilis) were chosen for PCR
to isolate the 16s rRNA gene. Instead of diluting the colonies in PBS
buffer as the protocol called for, the colony was directly placed onto
sterilized water and transferred onto the IBI Scientific PCR reagents
and IDT primers. The PCR products of the isolates were observed
with gel electrophoresis (1% agarose and ran at 100V for 30 min.).

RESULTS (CONTINUED)
Only MS-9-LB-B. subtilis and MS-36-TSA- B. subtilis were chosen
for gel extraction, sequencing, and biochemical tests, such as gramstains, catalase test, among others. The sequencing results were sent
back a couple of days later This sequence was inserted to the NCBI
BLAST program to compare it to known microorganism sequences
(6). The bacterial genus that was mostly related to the 16s rRNA
sequence of MS-36-TSA- B. subtilis is Pseudomonas. MS-9-LB-B.
subtilis was mostly related to the Bacillus genus, which is
interesting because it produced an antibiotic to another
microorganism of the same genus.

Fig. 3. 16s rRNA sequencing results MS-36-TSA- B. subtilis (top) and MS-9LB-B. subtilis (bottom). Isolate #36 is closely related ted the genus
Pseudomonas and Isolate #9 is related to the Bacillus genus, as determined by
BLAST (6).

DISCUSSION
Our bodies are becoming more resistant towards the ESKAPE
pathogens, along with other pathogens. Due to this antibiotic crisis,
it was decided to participate in TEPI. The results showed that some
of the soil isolates inhibited the growth of the other bacteria by
creating an antibiotic. These two isolates were sequenced and
proved to be part of the Pseudomonas and Bacillus genus, which are
common bacteria found in soil (7). B. subtilis is a known antibiotic
producer, therefore it was anticipated as one of the potential isolate
products (8). It would be beneficial to isolate the compound that is
actively responsible for producing the antibiotic using bioassayguided isolation, as explained by the TEPI manual. This study
confirms that soil is home to a diverse population of
microorganisms that can improve the current antibiotic crisis.
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